Synopsis of the 10th International Neurotrauma Symposium: from bench to bedside in neurotrauma translational research

References

• Maas AI, Steyerberg EW, Marmarou A et al. IMPACT recommendations for improving the design and analysis of clinical trials in moderate to severe traumatic brain injury. Neurotherapeutics7(1), 127–134 (2010).
   PubMed Web of Science ®Google Scholar
• Lingsma HF, Roozenbeek B, Li B et al. Large between-center differences in outcome after moderate and severe traumatic brain injury in the international mission on prognosis and clinical trial design in traumatic brain injury (IMPACT) study. Neurosurgery68(3), 601–607; discussion 607–608 (2011).
   PubMed Web of Science ®Google Scholar
• Manley GT, Diaz-Arrastia R, Brophy M et al. Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group. Arch. Phys. Med. Rehabil.91(11), 1667–1672 (2010).
   PubMed Web of Science ®Google Scholar
• Rosenfeld JV, Cooper J. What is the role for decompressive craniectomy in severe traumatic brain injury? Re: Decompressive craniectomy: surgical control of intracranial hypertension may improve outcome. Injury41(9), 899–900 (2010).
   PubMed Web of Science ®Google Scholar
• Pettila V, Cooper DJ. Treating intracranial hypertension: time to abandon mannitol? Crit. Care Resusc.11(2), 94–95 (2009).
   PubMed Web of Science ®Google Scholar
• Cooper DJ, Rosenfeld JV, Murray L et al. Decompressive craniectomy in diffuse traumatic brain injury. N. Engl. J. Med.364(16), 1493–1502 (2011).
   PubMed Web of Science ®Google Scholar
• Hutchinson PJ, Timofeev I, Kolias AG et al. Decompressive craniectomy for traumatic brain injury: the jury is still out. Br. J. Neurosurg.25(3), 441–442 (2011).
   PubMed Web of Science ®Google Scholar
• Roberts I, Shakur H, Afolabi A et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet377(9771), 1096–1101, 1101.e1–e2 (2011).
   PubMed Web of Science ®Google Scholar
• Maas AI, Harrison-Felix CL, Menon D et al. Standardizing data collection in traumatic brain injury. J. Neurotrauma28(2), 177–187 (2011).
   PubMed Web of Science ®Google Scholar
• Kwon BK, Sekhon LH, Fehlings MG. Emerging repair, regeneration, and translational research advances for spinal cord injury. Spine35(21 Suppl.), S263–S270 (2010).
   PubMed Web of Science ®Google Scholar
• Fehlings MG, Rabin D, Sears W, Cadotte DW, Aarabi B. Current practice in the timing of surgical intervention in spinal cord injury. Spine35(21 Suppl.), S166–S173 (2010).
   PubMed Web of Science ®Google Scholar
• Mac Donald CL, Johnson AM, Cooper D et al. Detection of blast-related traumatic brain injury in U.S. military personnel. N. Engl. J. Med.364(22), 2091–2100 (2011).
   PubMed Web of Science ®Google Scholar
• Yeo RA, Gasparovic C, Merideth F, Ruhl D, Doezema D, Mayer AR. A longitudinal proton magnetic resonance spectroscopy study of mild traumatic brain injury. J. Neurotrauma28(1), 1–11 (2011).
   PubMed Web of Science ®Google Scholar
• Chiu WT, Liao KH, Shigemori M, Cho KS, Jiang JY, Lin JW. Novel consensus of management guidelines for severe traumatic brain injury in Asia. J. Neurotrauma27(4), 775–776 (2010).
   PubMed Web of Science ®Google Scholar
• Donnelly DJ, Gensel JC, Ankeny DP, van Rooijen N, Popovich PG. An efficient and reproducible method for quantifying macrophages in different experimental models of central nervous system pathology. J. Neurosci. Methods181(1), 36–44 (2009).
   PubMed Web of Science ®Google Scholar
• Timofeev I, Czosnyka M, Carpenter K et al. Interaction between brain chemistry and physiology after traumatic brain injury: impact of autoregulation and microdialysis catheter location. J. Neurotrauma28(6), 849–860 (2011).
   PubMed Web of Science ®Google Scholar
• Ziebell JM, Morganti-Kossmann MC. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics7(1), 22–30 (2010).
   PubMed Web of Science ®Google Scholar
• Bye N, Habgood MD, Callaway JK et al. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp. Neurol.204(1), 220–233 (2007).
   PubMed Web of Science ®Google Scholar
• Thelin E, Johannesson L, Bellander BM. The temporal profiles in serum concentrations of the biomarker S100b in the first 48 hours after traumatic brain injury correspond to outcome. J. Neurotrauma28(5), A20–A20 (2011).
   Google Scholar
• Ponsford J, Shekleton J, Parcell D, Redman J, Phipps-Nelson J, Rajaratnam S. Sleep distrurbance and melatonin levels following traumatic brain injury. J. Neurotrauma28(5), A9–A10 (2011).
   Google Scholar
• Svetlov SI, Prima V, Kirk DR et al. Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. J. Trauma69(4), 795–804 (2010).
   PubMedGoogle Scholar
• Svetlov SI, Larner SF, Kirk DR, Atkinson J, Hayes RL, Wang KKW. Biomarkers of blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast brain injury. J. Neurotrauma26(6), 913–921 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang J, Calafiore M, Zeng Q et al. Electrically guiding migration of human induced pluripotent stem cells. Stem Cell Rev. DOI: 10.1007/s12015-011-9247-5 (2011) (Epub ahead of print).
   Google Scholar
• Ellis-Behnke RG, Schneider GE. Peptide amphiphiles and porous biodegradable scaffolds for tissue regeneration in the brain and spinal cord. Methods Mol. Biol.726, 259–281 (2011).
   PubMedGoogle Scholar
• Reeves T, Smith T, Lee N, Williamson J, Phillips L. Reduction in axon caliber following traumatic brain injury. J. Neurotrauma26(8), A86–A86 (2009).
   Google Scholar
• Reeves T, Lee N, Williamson J, Phillips L. Ultrastructural stereological analysis of unmyelinated axon damage in the corpus callosum following traumatic brain injury. J. Neurotrauma24(7), 1275–1275 (2007).
   Google Scholar
• Shear DA, Galani R, Hoffman SW, Stein DG. Progesterone protects against necrotic damage and behavioral abnormalities caused by traumatic brain injury. Exp. Neurol.178(1), 59–67 (2002).
   PubMed Web of Science ®Google Scholar
• Shear DA, Williams AJ, Sharrow K, Lu XC, Tortella FC. Neuroprotective profile of dextromethorphan in an experimental model of penetrating ballistic-like brain injury. Pharmacol. Biochem. Behav.94(1), 56–62 (2009).
   PubMed Web of Science ®Google Scholar
• Trabold R, Krieg S, Scholler K, Plesnila N. Role of vasopressin V(1a) and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice. J. Neurotrauma25(12), 1459–1465 (2008).
   PubMed Web of Science ®Google Scholar